Li Jing, Yang Guang-Zhi, Gao Lan-Xiang, Yan Wen-Xiu, Jin Hua, Li Lin
Department of Pathology, The General Hospital of Beijing Military Command, Beijing 100700;
Exp Ther Med. 2012 Jun;3(6):1015-1017. doi: 10.3892/etm.2012.529. Epub 2012 Mar 28.
In 1987, Carney et al described a rare thyroid tumor termed hyalinizing trabecular adenoma presenting characteristics consisting of a trabecular growth pattern and hyalinizing stroma. In subsequent reports, the observed nuclear features and RET alterations led this tumor to be linked to papillary carcinoma. Subsequent reports concerning hyalinizing trabecular carcinoma further complicated its classification. To avoid uncertainties, the definition of hyalinizing trabecular tumor (HTT) is more widely used. Herein, a case of HTT is reported in detail, and the circumstances are also discussed. HTT is thought to be particularly differentiated from papillary carcinoma despite the identical high frequency of nuclear grooves and cytoplasmic inclusions, and MIB-1-positive staining is one of the most accurate diagnostic methods due to the distinct membrane-positive pattern noted in HTT. It is believed that most HTTs are benign and lobectomy is the standard treatment. Pathologists should offer surgeons information concerning diagnosis overlapping with effective treatment.
1987年,卡尼等人描述了一种罕见的甲状腺肿瘤,称为透明变梁状腺瘤,其特征包括梁状生长模式和透明变基质。在随后的报告中,观察到的核特征和RET改变使这种肿瘤与乳头状癌联系起来。关于透明变梁状癌的后续报告进一步使其分类复杂化。为避免不确定性,透明变梁状肿瘤(HTT)的定义应用更为广泛。本文详细报告了一例HTT病例,并对相关情况进行了讨论。尽管核沟和胞质包涵体的出现频率相同,但HTT被认为与乳头状癌有明显区别,由于HTT中独特的膜阳性模式,MIB-1阳性染色是最准确的诊断方法之一。大多数HTT被认为是良性的,肺叶切除术是标准治疗方法。病理学家应向外科医生提供与有效治疗相关的诊断重叠信息。